RANOLAZINE and CHEST PAIN

Overview

CHEST PAIN is the #3 most commonly reported adverse reaction for RANOLAZINE, manufactured by A2A Integrated Pharmaceuticals. There are 605 FDA adverse event reports linking RANOLAZINE to CHEST PAIN. This represents approximately 3.9% of all 15,363 adverse event reports for this drug.

Patients taking RANOLAZINE who experience chest pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CHEST PAIN is moderately reported among RANOLAZINE users, representing a notable but not dominant share of adverse events.

Other Side Effects of RANOLAZINE

In addition to chest pain, the following adverse reactions have been reported for RANOLAZINE:

• DEATH — 817 reports
• MYOCARDIAL INFARCTION — 640 reports
• ANGINA PECTORIS — 594 reports
• STENT PLACEMENT — 582 reports
• DYSPNOEA — 419 reports
• DIZZINESS — 409 reports
• FALL — 368 reports
• CEREBROVASCULAR ACCIDENT — 355 reports
• CARDIAC DISORDER — 298 reports
• MALAISE — 278 reports

Other Drugs Associated with CHEST PAIN

The following drugs have also been linked to chest pain in FDA adverse event reports:

Does RANOLAZINE cause CHEST PAIN?

CHEST PAIN has been reported as an adverse event in 605 FDA reports for RANOLAZINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CHEST PAIN with RANOLAZINE?

CHEST PAIN accounts for approximately 3.9% of all adverse event reports for RANOLAZINE, making it one of the most commonly reported side effect.

What should I do if I experience CHEST PAIN while taking RANOLAZINE?

If you experience chest pain while taking RANOLAZINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages